Glucagon-like peptide-1 (GLP-1) agonists are a class of medications developed to treat type 2 diabetes mellitus
However, with modern data from millions of patients, the story has evolved
Concomitantly, autophagy was reported to also reduce the hepatocyte apoptosis caused by steatosis and endoplasmic reticulum stress, possibly through the GLP-1RA-stimulated GLP-1R-mediated activation of the EB transcription factor of the autophagy-lysosome pathway, thus reducing the accumulation of liver lipids (201)
Your Found clinician determines your starting dose and titration schedule based on your health history and treatment response
This is where peptides can play a role
Bariatric surgery itself increases endogenous GLP-1 levels, particularly after RYGB, contributing to improved glycemic control and weight loss